Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 12, 2020

SELL
$27.21 - $41.0 $489 - $738
-18 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$19.54 - $38.85 $351 - $699
18 New
18 $1,000
Q1 2018

Apr 13, 2018

SELL
$8.1 - $19.5 $1,328 - $3,198
-164 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$6.65 - $9.25 $1,090 - $1,517
164
164 $1,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $898M
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.